Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
The current price of CDIO is $1.56 USD — it has decreased by -1.27% in the past 24 hours. Watch Cardio Diagnostics stock price performance more closely on the chart.
What is Cardio Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cardio Diagnostics stocks are traded under the ticker CDIO.
Is Cardio Diagnostics stock price growing?▼
CDIO stock has fallen by -3.68% compared to the previous week, the month change is a -28.31% fall, over the last year Cardio Diagnostics has showed a -61.33% decrease.
What is Cardio Diagnostics market cap?▼
Today Cardio Diagnostics has the market capitalization of 4.62M
When is the next Cardio Diagnostics earnings date?▼
Cardio Diagnostics is going to release the next earnings report on September 02, 2026.
What is Cardio Diagnostics revenue for the last year?▼
Cardio Diagnostics revenue for the last year amounts to 15,000 USD.
What is Cardio Diagnostics net income for the last year?▼
CDIO net income for the last year is -6.5M USD.
How many employees does Cardio Diagnostics have?▼
As of July 30, 2026, the company has 15 employees.
In which sector is Cardio Diagnostics located?▼
Cardio Diagnostics operates in the Health & Wellness sector.
When did Cardio Diagnostics complete a stock split?▼
The last stock split for Cardio Diagnostics was on May 13, 2025 with a ratio of 1:30.
Where is Cardio Diagnostics headquartered?▼
Cardio Diagnostics is headquartered in Chicago, United States.